Indivior Share Price

Indivior Share Price

NASDAQ: INDV | Healthcare
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Indivior Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Indivior Share Price Chart

$0.00$0.00
L
Show Current Price
H

Indivior Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
9.52
Dividend Yield
0.00%
EPS (TTM)
$3.81
Revenue (TTM)
$1.24T
Return On Equity (TTM)
-750.00%
Profit Margin
16.95%
Debt to Equity
-8.13
Quarterly Earnings Growth YoY
34.31%

Indivior Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$358.00$317.00$343.00$356.00
Net Profit$102.00$89.00$122.00$137.00
Net Profit Margin28.49%28.08%35.57%38.48%
Income ChangeN/A-12.75%37.08%12.30%

Indivior Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$1093.00$1188.00$1239.00
Net Profit-$126.00$7.00$210.00
Net Profit Margin-11.53%0.59%16.95%
Income ChangeN/A105.56%2900.00%

Indivior Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets549.0489.0494.0
Current Assets652.0827.01266.0
Total Assets1201.01316.01760.0
Non Current Liabilities386.0729.0660.0
Current Liabilities914.0924.01290.0
Total Liabilities1300.01653.01950.0
Shareholders' Equity-99.0-337.0-190.0

Indivior Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-27.036.0-300.0
Investing-66.069.0-95.0
Financing-31.0-102.0-64.0

About Indivior

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Indivior Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %

Indivior Share Price FAQs